Endocrinological late effects following radiotherapy and chemotherapy of childhood brain tumours.
Schmiegelow
Marianne
M
Department of Endocrinology, Abdominal Centre, University Hospitality, H:S Rigshospitalet, Copenhagen, Denmark. mschmiegelow@hotmail.com
D000293:Adolescent; D001254:Astrocytoma / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy* / Q000601:surgery; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D019583:Dose Fractionation, Radiation; D004305:Dose-Response Relationship, Drug; D004307:Dose-Response Relationship, Radiation; D004700:Endocrine System Diseases / Q000453:epidemiology / Q000209:etiology*; D005260:Female; D013006:Growth Hormone / Q000172:deficiency / Q000378:metabolism; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology; D007031:Hypothalamus / Q000528:radiation effects; D007037:Hypothyroidism / Q000209:etiology; D007265:Inhibins / Q000097:blood; D008297:Male; D008527:Medulloblastoma / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D011879:Radiotherapy Dosage; D013736:Testicular Neoplasms / Q000097:blood; D013961:Thyroid Gland / Q000187:drug effects / Q000528:radiation effects; D013972:Thyrotropin / Q000097:blood; D013997:Time Factors
C422364:inhibin B; D007265:Inhibins; D013972:Thyrotropin; D013006:Growth Hormone